The effects of diazepam and Ro 15-1788 were assessed upon responses of mouse spinal cord (SC) neurons in cell culture to the amino ac ) neurotransmitters 4-aminobutyric acid (GABA) and S-glutamic acid. Diazepam 
We have investigated the effects of Ro 15-1788 upon GABA responses on mouse spinal cord (SC) neurons in cell culture and the enhancement of such responses by di,Jepam. We report that low concentrations of Ro 15-1788 (100 nM) antagonized diazepam enhancement of GABA responses, while higher concentrations (l ~M and 10 ~M) enhanced GABA responses, suggesting that Ro 15-1788 is a partial agonist at BZ receptors.
Cell cultures were prepared from SCs with attached dorsal root ganglia from 12-14-day-old mouse embryos, as described earlier [11, 141, and SC neurons (5-8 weeks in vitro) were penetrated on the modified stage of an inverted phase-contrast microscope, using high resistance (25-40 MO) glass micropipettes filled with either 4 M potassium acetate (KAc) or 3 M potassium chloride (KCI). Cultures were bathed in a phosphate-buffered saline (composition in raM: NaCI 143.4, KCI 4.2, CaCI2 0.9, MgCl2 I0.0 and glucose 5.6 in 9.5 mM sodium phosphate buffer at pH 7.35-7.40), and maintained at 33-34°C. Using a conventional bridge circuit, simultaneous current injection and membrane potential measurement were made with a single recording micropipette; data were recorded on a 6-channel Gould polygraph.
GABA (0.5 M, pH 3.2) or S-glutamate (0.5 M, pH 10.0) were applied iontophoretically using 400 ms rectangular current pulses ( + 0.5 to + 20 nA for GABA, -5 to -80 nA for S-glutamate) at 4 s intervals. Diazepam, Ro 15-1788 or vehicle (0.1°70 or less dimethylsulfoxide) were applied by miniperfusion (0.2 psi, 30 s) from a pipette 15-100 #m from the cell soma. Medium containing vehicle only did not alter responses to GABA or S-glutamate. GABA responses (KCI recordings) of 6-9 mV amplitude were evoked following membrane hyperpolarization to -80 to -90 mV, and glutamate responses (KAc recordings) of similar amplitude obtained near resting membrane potential (-60 to -70 mV) were used for assessment of drug actions. Data were accepted only if the amino acid responses returned to control levels within 5 rain following removal of the drug-containing pipette from the vicinity of the cell under study. Results are expressed as mean + standard error of the mean. When KAc recording micropipettes are used, application of GABA to SC neurons produces membrane hyperpolarization and an increase in membrane conductance [ ! 1 ]. Use of KCi-containing recording micropipettes allows chloride ions to enter the cell, changing the equilibrium potential for chloride ions from about -65 mV to -20 mV, and GABA responses become depolarizing [11] .
GABA responses were enhanced (65.0 +_ 3.007o) over control by 100 nM diazepam (n = 113 cells) in a reversible fashion (Fig. IAI) , and responses to S-glutamate were unaffected by 1 ~M diazepam (responses 98.9 +_ 1.0070 control, 10 cells, Fig. IA2 ), confirming previous studies demonstrating concentration-dependent enhancement of GABA responses by BZs in cultured avian and mouse SC and mouse cortical neurons [2, 9, 10, 20] the agonistic action of Ro 15-1788 is indeed 'partial' in nature. Ro 15-1788 (0.1 /~M-10/~M) did not alter membrane potential or conductance. Enhancement of GABA but not S-glutamate responses with absence of direct membrane actions suggests some selectivity in the effects of these BZs. In contrast, another anticonvulsant, phenobarbital, has been shown to inhibit S-glutamate responses and to produce membrane hyperpolarization by increasing chloride conductance, a GABAmimetic action [10] . Other BZ antagonists O-carboline-3-carboxylic acid methyl ester (//CCMe) and the ethyl ester (~CCEt) [7, 12] failed to affect GABA responses at 10 ~M (Fig. ICI, IC2 ) ~CCMe GABA responses 106.4 + 3.4% control, 6 cells;/3CCEt GABA responses 101.9 +_ 3.9% control, 8 cells). Thus, not all compounds with BZ antagonist activity exhibit agonist activity at high concentrations. Ro 15-1788 has been demonstrated to block diazepam enhancement of GABA effects in cat SC in vivo and isolated rat superior cervical ganglion [12, 13] . In the latter preparation very high Ro 15-1788 concentrations (167 #M and greater) enhanced GABA depolarization by approximately 20°70 [12] . Neurochemical studies have shown a potent antagonism of diazepam-enhanced GABA binding by Ro 15-1788 (IC5o = 5 nM) but have not revealed enhancement of GABA binding [8, 17] . These assays were performed at 2°C; since the potency of diazepam as an enhancer of GABA binding increases severalfold at 25°C [16] , it may be possible that high concentrations of Ro 15-1788 would enhance GABA binding upon assay at physiological temperature.
A recent study [7] has examined the relationship between in vivo receptor occupancy by various BZ receptor ligands and their activity against audiogenic seizures in DBA/2 mice. Ro 15-1788, but not 0CCMe or 0CCEt, was found to have anticonvulsant activity. Further, the doses required for the anticonvulsant activity of Ro 15-1788 were some 150-fold higher than for diazepam. Whereas classical BZ agonists had anticonvulsant activity in this model at low receptor occupancy (< 10~/e), almost complete occupancy by Ro 15-1788 was required for its anticonvulsant activity. These results, together with the differing concentration-dependencies of GABA enhancement by diazepam and Ro 15-1788, suggest that different levels of receptor occupancy by the two compounds may be required for the enhancement of GABA receptor affinity.
The partial agonist activity of Ro 15-1788 at high doses or concentrations should be taken into account when the compound is used experimentally and clinically. Ro 15-1788 has been proposed as combination therapy to counteract the sedative effects of the antischistosomal BZ 3-methylclonazepam [6] and may be useful in BZ overdose cases. While Ro 15-1788 lacks sedative activity in man at doses of 600 rag/day and lower [4] , higher doses could possibly cause sedation or tolerance.
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